MSMolly J. Sullan

Molly J. Sullan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Molly J. Sullan has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Impact of a Sleep Enhancement Protocol on Nighttime Room Entries in an Inpatient Rehabilitation Facility

    by Molly J. Sullan, Bhumi B. Bs Patel, Russell M. Bauer, Michael S. Jaffee

    Purpose: This study examined whether a sleep enhancement protocol (SEP) could reduce nighttime room entries (NREs) for patients with orthopedic injury (OI) or acquired brain injury (ABI) in an inpatient rehabilitation facility. Design: A two-wave prospective study assessing standard of care (SOC) versus SEP. Methods: Sixty-five participants completed baseline and follow-up questionnaires and wore an actigraph for approximately 7 days. In the SEP, nighttime care was “bundled.” Findings: In SOC, NREs were associated with less efficient sleep and greater daytime fatigue. Nighttime room entries were approximately 50% lower in the SEP than SOC. Participants in the OI SOC had more room entries than any other group. There were no significant changes in room entries in the ABI SEP group. Conclusions: There was a relationship between NREs and sleep. The SEP was effective at reducing NREs for patients with OI, but not ABI. Clinical Relevance: Sleep enhancement protocols in inpatient rehabilitation facilities may be effective at improving sleep. Future research may focus on developing individualized protocols to improve sleep across patients with a variety of presenting diagnoses.


  • Glymphatic system disruption as a mediator of brain trauma and chronic traumatic encephalopathy

    by Molly J. Sullan, Breton M. Asken, Michael S. Jaffee, Steven T. DeKosky, Russell M. Bauer


  • Factors Influencing Clinical Correlates of Chronic Traumatic Encephalopathy (CTE): a Review

    by Breton M. Asken, Molly J. Sullan, Aliyah R. Snyder, Zachary M. Houck, Vaughn E. Bryant, Loren P. Hizel, Molly E. McLaren, Duane E. Dede, Michael S. Jaffee, Steven T. DeKosky, et al.

    Chronic traumatic encephalopathy (CTE) is a neuropathologically defined disease reportedly linked to a history of repetitive brain trauma. As such, retired collision sport athletes are likely at heightened risk for developing CTE. Researchers have described distinct pathological features of CTE as well a wide range of clinical symptom presentations, recently termed traumatic encephalopathy syndrome (TES). These clinical symptoms are highly variable, non-specific to individuals described as having CTE pathology in case reports, and are often associated with many other factors. This review describes the cognitive, emotional, and behavioral changes associated with 1) developmental and demographic factors, 2) neurodevelopmental disorders, 3) normal aging, 4) adjusting to retirement, 5) drug and alcohol abuse, 6) surgeries and anesthesia, and 7) sleep difficulties, as well as the relationship between these factors and risk for developing dementia-related neurodegenerative disease. We discuss why some professional athletes may be particularly susceptible to many of these effects and the importance of choosing appropriate controls groups when designing research protocols. We conclude that these factors should be considered as modifiers predominantly of the clinical outcomes associated with repetitive brain trauma within a broader biopsychosocial framework when interpreting and attributing symptom development, though also note potential effects on neuropathological outcomes. Importantly, this could have significant treatment implications for improving quality of life.